0.52; P = 0.001) but did not reach statistical significance in those who were switched because of unacceptable toxicity (0.61 vs. 0.47; P ≥ 0.05).
← all excerpts
Clinical utility of glatiramer acetate in the management of relapse frequency in multiple sclerosis.
1
0.0500
0.0500